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1008ABSTRACT
Background. Graft dysfunction after liver transplantation is a serious complication that
can lead to graft loss and patient death. This was a study to identify risk factors for early
death (up to 30 days after transplantation).
Methods. It was an observational and retrospective analysis at the Liver Transplantation
Unit, Hospital de Clinicas, State University of Campinas, Brazil. From July 1994 to
December 2012, 302 patients were included (>18 years old, piggyback technique). Of these
cases, 26% died within 30 days. For analysis, Student t tests and chi-square were used to
analyze receptor-related (age, body mass index, serum sodium, graft dysfunction, Model
for End-Stage Liver Disease score, renal function, and early graft dysfunction [EGD type 1,
2, or 3]), surgery (hot and cold ischemia, surgical time, and units of packed erythrocytes
[pRBC]), and donor (age, hypotension, and brain death cause) factors. Risk factors were
identified by means of logistic regression model adjusted by the Hosmer-Lemeshow test
with significance set at P < .05.
Results. We found that hyponatremic recipients had a 6.26-fold higher risk for early
death. There was a 9% reduced chance of death when the recipient serum sodium
increased 1 unit. The chance of EGD3 to have early death was 18-fold higher than for
EGD1 and there was a 13% increased risk for death for each unit of pRBC transfused.
Conclusions. Donor total bilirubin, hyponatremia, massive transfusion, and EGD3 in the
allocation graft should be observed for better results in the postoperative period.*Address correspondence to I.F.S.F. Boin, Rua Aldo Oliveira
Barbosa 184, CampinasdSP, Brazil, CEP 13086-030. E-mail:
ilkaboin@yahoo.comACCORDING to data from the Brazilian Organ Trans-plant Association (ABTO) [1], 16,186 liver transplants
were performed in Brazil from 2003 to 2012, and there were
w7,005 patients on the liver transplant waiting list [2].
Because, invariably, major surgeries are performed on pa-
tients under difficult clinical conditions owing to advanced
chronic liver disease, the risk of complications can lead to
graft rejection requiring retransplantation and receptor
death [2e4].
The vast majority of deaths occurred in the first 30 days
after surgery, and although much effort has been made to
find an early diagnosis and treatment of complications, it is
still insufficient to minimize the suffering while waiting on
the transplant list. Primary nonfunction (PNF) is the main
cause for early graft loss, with an incidence ranging from 2%
to 23%, as shown by some studies [5,6]. Its etiology remains
unknown, although some factors related to the donor at the5
.org/10.1016/j.transproceed.2015.03.015time of reperfusion, among others, are closely related to the
occurrence of PNF [7,8].
Vascular complications after liver transplantation (LT)
are another important reason for graft loss, with an inci-
dence ranging from 2.6% to 20%, the most severe being
hepatic artery thrombosis [8e12].
A previous analysis carried out by our service showed that
the major causes of graft loss and death of the patient within 30
days are early graft dysfunction and coagulopathy, respectively
[13,14].
The present study aimed to analyze and identify the risk
factors for early death defined as occurring in the first 30
days after LT.ª 2015 by Elsevier Inc. All rights reserved.
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Table 1. Descriptive Demographic and Clinical Data from
Qualitative Recipients’ and Liver Donors’ Variables According to
Status of Early Death or Alive
Early Death Alive P Value
Recipients’ variables
Sex
Female 23 (28.0%) 59 (72.0%) .38
Male 51 (23.2%) 169 (76.8%)
Aging
No 60 (23.7%) 193 (76.3%) .46
Yes 14 (28.6%) 35 (71.4%)
Obesity
No 58 (22.7%) 197 (77.3%) .09
Yes 16 (34.0%) 31 (66.0%)
Diabetes
No 56 (23.4%) 183 (76.6%) .26
Yes 16 (30,8%) 36 (69.2%)
Hyponatremia
A 57 (22.8%) 193 (77.2%) .13
B 17 (32.7%) 35 (67.3%)
EGD
EGD1 4 (3.4%) 113 (96.6%) .001
EGD2 7 (8.8%) 73 (91.2%)
EGD3 13 (28.3%) 33 (71.1%)
CTP
A 5 (19.2%) 21 (80.8%) .03
B 17 (17.7%) 79 (82.3%)
C 52 (28.9%) 128 (71.1%)
Sepsis
Yes 9 (27.3%) 24 (72.7%) .06
No 65 (24.2%) 204 (75.8%)
HAT
Yes 6 (50.0%) 6 (50.0%) .03
No 68 (23.4%) 222 (76.6%)
Donors’ variables
Age
<50 y 62 (24.4%) 192 (75.6%) .88
Brain death cause
Anoxia 14 (29.8%) 33 (70.2%) .34
Trauma 7 (22.6%) 24 (77.4%)
Other 52 (23.4%) 170 (76.6%)
Arterial hypotension
Yes 12 (17.6%) 56 (82.4%) .13
No 62 (26.6%) 171 (73.4%)
Abbreviations: EGD, early graft dysfunction; CTP, Child-Turcotte-Pugh clas-
sification; HAT, hepatic arterial thrombosis.
Table 2. Descriptive Demographic and Clinical Data from
Quantitative Recipients’ and Liver Donors’ Variables According
to Status of Early Death or Alive
Early Death Alive P Value
Recipients’ variables
Age (y) 50.0  9.8 47.8  10.9 .099
Body mass index (kg/m2) 26.6  5.1 25.7  4.1 .193
Serum sodium (mEq/L) 134.3  7.3 135.3  5.2 .269
ALT max (UI/L) 5132  4378 1635  2203 <.001
MELD score 21.0  7.3 18.4  5.6 .004
GFR (mL/min) 98.5  52.9 101.5  40.7 .656
Warm ischemia (min) 74.7  43.6 58.1  16.9 .003
Cold ischemia (min) 675.1  205.1 646.5  194.6 .697
Surgical time (min) 536  168.3 502.3  134.2 .122
pRBC (units) 13.0  10.2 5.0  4.5 <.001
Donors’ variables
Age (y) 33.6  13.4 34.2  13.6 .743
Total bilirubin (mg/dL) 0.92  0.7 0.78  0.62 .137
Serum sodium (mEq/L) 155.4  16.3 151.8  14.8 .093
Abbreviations: ALT max, maximum alanine aminotransferase up to 30th
postoperative day; MELD, Model for End-Stage Liver Disease; GFR, glomerular
filtration rate; pRBC, packed red blood cells.
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This was an observational, cross-sectional and retrospective study
through medical records and the prospective electronic database
from the Unit of Liver Transplantation, Hospital de Clínicas, State
University of Campinas, and the São Paulo Health Transplant
System.
A total of 302 liver transplantations in adult patients from July
1994 to December 2012 with the use of the piggyback technique
were included in this analysis. We excluded patients submitted to
retransplantation, liver-kidney transplantation, and acute liver fail-
ure as cause for transplantation. All patients received liver grafts
from deceased donors. We considered early death when the event
occurred up to the 30th postoperative day and the patients weredistributed according to this event: dead versus alive. For diagnosis
of primary graft failure and early graft dysfunction the following
classification [2] was used:
 Primary nonfunction (PNF): patients who died within the 1st 7 days
with aspartate aminotransferase (AST) >5,000 UI/L, international
normalized ratio (INR) 2.5 or acidosis, arterial pH <7.30 or
venous pH <7.25, or lactate 4 mmol/L according to the United
Network of Organ Sharing (UNOS).
 Early graft dysfunction (EGD): according to the following
definitions, the classification used by Boin et al in 2008 [4],
adapted from Heise and other criteria in 2003 [5]: a) EGD1:
patients who died within 30 days with maximum alanine
aminotransferase (ALT) >1,000 IU/L; b) EGD2: ALT
1,001e2,499 IU/L; c) EGD3: ALT >2,500 IU/L [2].
Other complications defined were:
 Hepatic artery thrombosis (HAT): thrombosis diagnosed with the
use of a Doppler ultrasonography or computerized tomography
with contrast or during surgical procedure.
 Glomerular filtration rate (GFR): as estimated with the use of the
Cockcroft-Gault formula: [140  age (y)]  weight (kg)/creatinine
(mg/dL)  72 ( 0.85 if female) [15].
 Sepsis: defined by the criteria of critical care medicine [2,13].
 Cardiac arrest (CA): the patient died during surgery owing to
cardiac arrest in the preoperative period.
The preservation solution used in the period 1991e2009 was the
Belzer solution (WS), and in 2010 we started to use the HTK so-
lution. All patients underwent standard immunosuppressive therapy
based on calcineurin inhibitors: cyclosporine (CsA; 4e8 mg/kg) or
FK506 (0.1 mg/kg) and steroids until the 180th day after trans-
plantation with tapering and withdrawal. The CsA blood level was
200e400 ng/mL in the 1st 3 months and 150e250 ng/mL for another
month. The FK506 blood level was 8e12 ng/mL in the 1st 3 months
and 5e10 for another month [7].
The recipients’ quantitative variables studied were: age (y), body
mass index (BMI; kg/m2), serum sodium (mEq/L), Model for End-
Stage Liver Disease (MELD) score [16], warm ischemia time (min),
cold ischemia time (min), surgical time (min), and packed red blood
Table 3. Logistic Regression Model Applied to Recipients’
Variables Stratifying to Hyponatremic Patients According to
Early Death
Variables Beta OR 95% CI P Value
Sodium 0.098 0.91 0.84e0.98 .01
EGD3 2.880 17.76 4.24e74.32 .001
pRBC 0.125 1.13 1.04e1.24 .005
Abbreviations: OR, odds ratio; CI, confidence interval; other abbreviations as
in Tables 1 and 2.
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dead/alive (after 30th postoperative day), sex (male/female), aging
(yes/no), obesity (yes/no, BMI >30 kg/m2), diabetes (yes/no, gly-
cemia >125 mg/dL), hyponatremia (yes/no, serum sodium <130
mEq/L), Child-Turcotte-Pugh classification (CTP score A, B, or C)
[17], and etiology of recipient’s hepatic disease.
The donors’ quantitative variables were: age (y), total bilirubin
(mg/dL), and serum sodium (Na, mEq/L). The qualitative variables
were: aging (yes/no, >50 years), arterial hypertension (yes/no), and
cause of brain death (anoxia, trauma, or other).
The quantitative variables were analyzed with the use of
descriptive statistics and Student t test, and categoric variables with
the use of chi-square test, applying Fisher exact test when necessary.
When the variables had P values <.25 in those tests, we applied
Hosmer-Lemeshow test to adjust selection criteria after we applied
a logistic regression model to identify risk factors. The significant P
value was <.05.
RESULTS
Seventy-four patients (24.5%) died by the 30th post-
operative day and 228 (75.5%) were alive. Hepatitis C
associated or not with alcohol was present in 32/74 (43.2%)
and 106/228 (46.5%) of the cases.
The major cause of recipient early death was PNF (24/74,
32.4%) followed by CA (8/74, 10.8%). The qualitative re-
cipients’ and liver donors’ descriptive statistics are presented
in Table 1.
When the quantitative variables were compared accord-
ing to early-death versus alive patients we can observe that
early-death patients had higher MELD score (21  7.3;
range, 7e46; P ¼ .004); max ALT (5,132  4,378 IU/L;
range, 274e22,700; P < .001); pRBC (13.0  10.2 units;
range, 0e62; P< .001), and warm ischemia time (74.2  46.6
min; range 30e155). These and the other variables are
presented in Table 2. As a result we found that hypona-
tremic recipients had 6.26 times higher risk for early death.
According to Table 3, we can observe that there is a 9%
reduced chance of death when the recipient serum sodium
increases 1 unit. The chance of patients with EGD3 having
early death is 18 times greater than for patients with EGD1,
and there is a 13% increased risk of death for each unit of
pRBC transfused.
DISCUSSION
Although many studies describe the relationship between
the occurrence of PNF and EGD [5e7], we observed in our
study that 24.5% patients died in the early period after LTand the great majority owing to PNF. EGD3 was a major
risk factor for such death (an almost 18-fold increase).
Similar results are described in the literature [2,6,7].
We observed that high MELD score, CTP C, or severe
patients with major complications and mortality were associ-
ated with HAT as a risk factor for early death, as reported in
the literature [2,17,18].
Long warm ischemia time was associated with either early or
long-term death, as reported in the literature [2,5,13,19e21].
Vrochides et al also reported that parameters that were iden-
tified with early postoperative mortality were CTP score,
MELD score, bilirubin, creatinine, INR, and warm ischemia
time [21].
In the present study, hyponatremic patients showed a
6-fold higher risk for early death. Leise et al [22] reported
that there was no difference in in-hospital mortality or
90-day survival between patients with hyponatremia and
patients with normonatremia. After adjustments for important
clinical variables, the association of pre-LT hypernatremia
with post-transplantation mortality remained significant with a
hazard ratio of 1.13 for each unit increase in the Na level
>145 mEq/L (P < .001). The duration of hospitalization after
LT was significantly longer for hypernatremic patients (P <
.001), and the authors concluded that pre-LT hypernatremia is
a highly significant risk factor for post-LT mortality, as we
observed in our study.
Many studies have reported allogeneic blood transfusions
to be associated with adverse effects in recipients [19].
Although some data show the relationship between the
amount of transfused pRBC and poor outcome after LT,
the mechanism is unknown. Blood transfusion can interfere
with the immune system of the recipient [20]; residual
amounts of donor leukocytes present in red blood as well as
preservation-related changes in erythrocytes and a duration
of storage of transfused blood are important risk factors for
poor outcome after LT [23].
In conclusion, hyponatremia, massive transfusion, and
severe EGD should be observed in the allocation graft for
better results in the postoperative period.REFERENCES
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